Mutations in APC occur in approximately 70%–80% of human colon tumors, which activate the Wnt/beta-catenin pathway to induce beta-catenin to form complexes with the TCF/LEF nucleus partner in the nucleus, subsequently regulating the expression of beta-catenin target genes [29]. Here, APC is linked to colonic neoplasm.